Shopping Cart 0
Cart Subtotal
AED 0

Siemens Healthcare GmbH (SHL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Siemens Healthcare GmbH (Siemens Healthineers), a subsidiary of Siemens AG, is a global medical device company that designs, develops, manufactures and distributes medical devices and technologies for diagnostic markets. Its major products include healthcare IT, laboratory diagnostics equipment, medical imaging equipment, point-of-care testing devices, devices for clinical specialties and diseases, and medical accessories, OEM component and medical electronics solutions. Its products and solutions are utilized in cardiology, neurology, oncology, surgery, women's health, diabetes, infectious disease, urology, organ transplant, therapeutic drug monitoring and growth disorders, among others. The company operates in Europe, the Americas, the Middle East, Africa and Asia-Pacific. Siemens Healthineers is headquartered in Erlangen, Germany.

Siemens Healthcare GmbH (SHL)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Siemens Healthcare GmbH, Medical Devices Deals, 2012 to YTD 2018 9

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

NEO New Oncology Raises USD5.6 Million in Financing Round 11

Partnerships 12

Siemens Healthcare Enters into Co-Development Agreement with Biogen 12

New Oncology Enters into Research Agreement with Gustave Roussy Cancer Campus 13

Equity Offering 14

Siemens Healthcare Raises USD5.71 Billion in IPO 14

Siemens Healthcare GmbH-Key Competitors 16

Siemens Healthcare GmbH-Key Employees 17

Siemens Healthcare GmbH-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Joint Venture 21

Recent Developments 22

Strategy And Business Planning 22

Oct 05, 2018: Siemens Healthineers celebrates the opening of its new corporate headquarters in Erlangen 22

Jun 30, 2017: Siemens Breaks Ground in Walpole, Mass., Marks Milestone in its Investment Strategy for Healthcare Market Transformation 23

Financial Announcements 24

Jul 30, 2018: Siemens Healthineers: Strong comparable revenue growth and accelerating Atellica shipments 24

May 03, 2018: Siemens Healthineers fully on track to meet the targets 26

Corporate Communications 27

Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 27

Nov 29, 2017: Siemens plans to list Siemens Healthineers on Frankfurt Stock Exchange 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Siemens Healthcare GmbH, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Siemens Healthcare GmbH, Deals By Therapy Area, 2012 to YTD 2018 8

Siemens Healthcare GmbH, Medical Devices Deals, 2012 to YTD 2018 9

Siemens Healthcare GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

NEO New Oncology Raises USD5.6 Million in Financing Round 11

Siemens Healthcare Enters into Co-Development Agreement with Biogen 12

New Oncology Enters into Research Agreement with Gustave Roussy Cancer Campus 13

Siemens Healthcare Raises USD5.71 Billion in IPO 14

Siemens Healthcare GmbH, Key Competitors 16

Siemens Healthcare GmbH, Key Employees 17

Siemens Healthcare GmbH, Other Locations 18

Siemens Healthcare GmbH, Subsidiaries 20

Siemens Healthcare GmbH, Joint Venture 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Siemens Healthcare GmbH, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.